REPAGYN
REPAGYN, licence 80039889: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Farma-Derma s.r.l.
- NPN or DIN-HM
- 80039889
- Status
- Active licence
- Licence date
- 14 February 2013
- Revision date
- 22 October 2020
- Form
- Suppositoire
- Route of administration
- Vaginale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Glycérides de palmiste hydrogénes, Huile essentielle d'arbre à thé, Ext. de Calendula Officinalis, NA, Jus de feuilles d'Aloe Barbadensis, Glycérides de palme hydrogénés, Extrait de Centella asiatica
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 suppositoire | 1.0 Tous les jours |
Uses authorised in Canada
It helps relieve dryness and helps to promote healing of vaginal mucosa.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Interactions with other products are not known, therefore it is advisable to consult the health care practitioner before to use Repagyn in association with other products for vaginal use. Do not use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen. Keep the product out of the reach and sight of children. Avoid contact with eyes. Do not swallow.
Source
Official Health Canada record, licence 80039889
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.